GlassScriptPhysician profile
Justin Britz
NPI 1548864499
$4,050.16
in general payments reported to CMS, 2019-2025
15 companies · $789 in 2025
The $789 reported for 2025 was more than what 85% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $994 · 2022: $611 · 2023: $882 · 2024: $774 · 2025: $789.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,445.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,445.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Getinge USA Sales, LLC | $1,334.49 | 2021-2024 | Cardiohelp, Flixene, Vasoview Hemopro 2 |
| Edwards Lifesciences Corporation | $479.81 | 2022-2025 | Konect Resilia, Inspiris Resilia Aortic Valve |
| Atricure, INC. | $356.80 | 2021-2025 | Atricure Cryoice Cryoablation System (Cryo2) |
| Lilly USA, LLC | $302.38 | 2023-2024 | Mounjaro |
| Baxter Healthcare | $247.72 | 2022-2024 | Floseal, Coseal, Preveleak |
| Abiomed | $216.22 | 2025 | |
| Abbvie INC. | $207.42 | 2024 | |
| Inari Medical, INC. | $183.17 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Novo Nordisk INC | $169.60 | 2023-2025 | Ozempic |
| Astrazeneca Pharmaceuticals LP | $124.96 | 2021 | |
| Janssen Pharmaceuticals, INC | $121.54 | 2023 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $118.16 | 2023 | Eliquis |
| Depuy Synthes Sales INC. | $85.67 | 2025 | Trufill |
| Davol INC. | $70.32 | 2022 | |
| Boston Scientific Corporation | $31.90 | 2023-2025 | Lithovue |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Britz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.